FIL‐PTCL13: PHASE IB/II STUDY OF ROMIDEPSIN/CHOEP FOLLOWED BY HIGH‐DOSE CHEMOTHERAPY AND TRANSPLANTATION IN UNTREATED PERIPHERAL T‐CELL LYMPHOMAS.
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2440_10
Abstract: FIL‐PTCL13: PHASE IB/II STUDY OF ROMIDEPSIN/CHOEP FOLLOWED BY HIGH‐DOSE CHEMOTHERAPY AND TRANSPLANTATION IN UNTREATED PERIPHERAL T‐CELL LYMPHOMAS. A. Chiappella* | C. Carniti | M. Ceccarelli | M.G. Cabras | A. Re | F. Salvi |… read more here.
Keywords: behalf fondazione; hematology; fondazione italiana; fil ... See more keywords
Commutativity in the lattice of topologizing filters of a ring – localization and congruences
Sign Up to like & getrecommendations! Published in 2019 at "Acta Mathematica Hungarica"
DOI: 10.1007/s10474-019-00919-4
Abstract: Abstract The order dual $${[{\rm Fil}{R_{R}}]^{{\rm du}}}$$[FilRR]du of the set $${{\rm Fil}{R_{R}}}$$FilRR of all right topologizing filters on a fixed but arbitrary ring R is a complete lattice ordered monoid with respect to the (order… read more here.
Keywords: mathfrak; fil; lattice; fil filrr ... See more keywords
Development and evaluation of a self-cleaning custom-built auto sampler controlled by a low-cost RaspberryPi microcomputer for online enzymatic activity measurements.
Sign Up to like & getrecommendations! Published in 2017 at "Talanta"
DOI: 10.1016/j.talanta.2016.10.031
Abstract: A fully automated on-site device (SAMP-FIL) that enables water sampling with simultaneous filtration and effective cleaning procedures of the device's components was developed and field-tested. The SAMP-FIL was custom-built using commercially available components and was… read more here.
Keywords: custom built; enzymatic activity; fil; low cost ... See more keywords
THU0173 FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGICAL DMARDS (BDMARD-IR) BY RACE & GEOGRAPHIC REGION
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.2323
Abstract: Background Filgotinib (FIL), an oral, selective Janus kinase 1 (JAK1) inhibitor, significantly improved the signs and symptoms of rheumatoid arthritis (RA) in the phase 3 FINCH2 study in bDMARD-IR patients with active RA.1 Objectives To… read more here.
Keywords: fil; region; ltd; fil 200 ... See more keywords
THU0194 SELECTIVE INHIBITION OF JANUS KINASE 1 (JAK1) BY FILGOTINIB MODULATES THE DISEASE-ASSOCIATED WHOLE BLOOD TRANSCRIPTIONAL PROFILE OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.2509
Abstract: Background Filgotinib (FIL), an oral selective JAK1 inhibitor, was safe and efficacious in FINCH2, a randomized, double-blind, placebo-controlled, phase 3 study in patients with active rheumatoid arthritis (RA) who had an inadequate response to biologic… read more here.
Keywords: gilead sciences; sciences inc; gilead; fil ... See more keywords